White label ELPA - ClinicalTrials.eu

A study of SKB410, enfortumab vedotin, and pembrolizumab combination for patients with locally advanced or metastatic urothelial cancer

Recruiting

1 1 1 1
Investigated Diseases:
- Transitional cell carcinoma
Investigated Drugs:
- SKB410
- Pembrolizumab
Study of ublituximab compared to fingolimod for children and teenagers aged 10 to 17 years with relapsing multiple sclerosis

Recruiting

4 1 1
Investigated Diseases:
- Relapsing multiple sclerosis
Investigated Drugs:
- Fingolimod
- Ublituximab
A study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis

Recruiting

2 1
Investigated Diseases:
- Acute kidney injury
+3
A Study of Prednisolone, Mycophenolate Mofetil and Voclosporin Compared to Prednisolone and Mycophenolate Mofetil in Patients with Lupus Nephritis

Recruiting

3 1 1 1
Investigated Diseases:
- Lupus nephritis
Investigated Drugs:
- Voclosporin
A study testing prednisone combined with antibiotics compared to antibiotics alone in adults with septic arthritis to improve joint health

Recruiting

3 1 1
Investigated Diseases:
- Arthritis infective
Investigated Drugs:
- Prednisone
A Study of IPN01203 for Adults With Advanced or Metastatic Solid Tumors After Immune Checkpoint Inhibitor Treatment

Recruiting

2 1 1
Investigated Diseases:
- Metastatic neoplasm
Study comparing treatment with or without tislelizumab for patients with locally advanced rectal cancer to see if surgery can be avoided

Recruiting

2 1 1
Investigated Drugs:
- Tislelizumab
A Study of IPN60300 in Adults with Locally Advanced or Metastatic Solid Tumors to Assess Safety, Tolerability and Anti-Cancer Activity

Recruiting

2 1 1
Investigated Diseases:
- Neoplasm malignant
A Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease

Recruiting

2 1

+1
Study comparing firmonertinib with osimertinib or afatinib for patients with advanced lung cancer with uncommon EGFR mutations

Recruiting

3 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies